Literature DB >> 21203976

A novel CARD containing splice-isoform of CIITA regulates nitric oxide synthesis in dendritic cells.

Dachuan Huang1, Sylvia Lim, Rong Yuan Ray Chua, Hong Shi, Mah Lee Ng, Siew Heng Wong.   

Abstract

MHC class II expression is controlled mainly at transcriptional level by class II transactivator (CIITA), which is a non-DNA binding coactivator and serves as a master control factor for MHC class II genes expression. Here, we describe the function of a novel splice-isoform of CIITA, DC-expressed caspase inhibitory isoform of CIITA (or DC-CASPIC), and we show that the expression of DCCASPIC in DC is upregulated upon lipopolysaccharides (LPS) induction. DC-CASPIC localizes to mitochondria, and protein-protein interaction study demonstrates that DC-CASPIC interacts with caspases and inhibits its activity in DC. Consistently, DC-CASPIC suppresses caspases-induced degradation of nitric oxide synthase-2 (NOS2) and subsequently promotes the synthesis of nitric oxide (NO). NO is an essential regulatory molecule that modulates the capability of DC in stimulating T cell proliferation/activation in vitro; hence, overexpression of DC-CASPIC in DC enhances this stimulation. Collectively, our findings reveal that DC-CASPIC is a key molecule that regulates caspases activity and NO synthesis in DC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21203976      PMCID: PMC4875089          DOI: 10.1007/s13238-010-0039-5

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  37 in total

Review 1.  Genetic control of MHC class II expression.

Authors:  Jenny Pan-Yun Ting; John Trowsdale
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity.

Authors:  K Nickerson; T J Sisk; N Inohara; C S Yee; J Kennell; M C Cho; P J Yannie; G Nunez; C H Chang
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

3.  Translational regulation of angiotensin II type 1A receptor. Role of upstream AUG triplets.

Authors:  Y Mori; H Matsubara; S Murasawa; K Kijima; K Maruyama; H Tsukaguchi; N Okubo; T Hamakubo; T Inagami; T Iwasaka; M Inada
Journal:  Hypertension       Date:  1996-11       Impact factor: 10.190

Review 4.  Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase.

Authors:  G C Brown
Journal:  FEBS Lett       Date:  1995-08-07       Impact factor: 4.124

5.  Nitric oxide production and mitochondrial dysfunction during rat thymocyte apoptosis.

Authors:  J Bustamante; G Bersier; M Romero; R A Badin; A Boveris
Journal:  Arch Biochem Biophys       Date:  2000-04-15       Impact factor: 4.013

6.  Inhibition of corticotropin releasing hormone type-1 receptor translation by an upstream AUG triplet in the 5' untranslated region.

Authors:  G Xu; C Rabadan-Diehl; M Nikodemova; P Wynn; J Spiess; G Aguilera
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

7.  Nitric oxide synthase activity in mitochondria.

Authors:  P Ghafourifar; C Richter
Journal:  FEBS Lett       Date:  1997-12-01       Impact factor: 4.124

8.  The modulation of mitochondrial nitric-oxide synthase activity in rat brain development.

Authors:  Natalia A Riobo; Mariana Melani; Norberto Sanjuan; Monica L Fiszman; Maria Clara Gravielle; M Cecilia Carreras; Enrique Cadenas; Juan J Poderoso
Journal:  J Biol Chem       Date:  2002-08-28       Impact factor: 5.157

9.  Nitric-oxide synthase 2 interacts with CD74 and inhibits its cleavage by caspase during dendritic cell development.

Authors:  Dachuan Huang; Deyu Tarika Cai; Rong Yuan Ray Chua; David Michael Kemeny; Siew Heng Wong
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

Review 10.  Pushing the limits of the scanning mechanism for initiation of translation.

Authors:  Marilyn Kozak
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.